DNA hypomethylating agent
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DNA hypomethylating agent, covering 2020-09-09 to 2020-09-09. Get the full timeline:
Most recent: Clinical Trial Update: Combined Inhibition of PD-1 and DNA Hypomethylating Agent +/- Chemotherapy in High-risk AML or Elderly Patients With AML Who Are Unfit for Intensive Chemotherapy [Phase 2]